(Q37026641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Creating immune privilege: active local suppression that benefits friends, but protects foes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Andrew L Mellor

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Immunology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

74-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

Unique human tumor antigens: immunobiology and use in clinical trials

29 December 2019

cites work

1 reference

A historical perspective on immunological privilege

31 March 2020

1 reference

Ocular autoimmunity: the price of privilege?

31 March 2020

1 reference

See no evil, hear no evil, do no evil: the lessons of immune privilege

31 March 2020

1 reference

CNS immune privilege: hiding in plain sight

31 March 2020

1 reference

The testis in immune privilege

31 March 2020

1 reference

Regulatory T cells and organ transplantation

31 March 2020

1 reference

T cell awareness of paternal alloantigens during pregnancy

31 March 2020

1 reference

Expanded cohorts of maternal CD8+ T-cells specific for paternal MHC class I accumulate during pregnancy

31 March 2020

1 reference

Prevention of allogeneic fetal rejection by tryptophan catabolism

31 March 2020

1 reference

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

31 March 2020

1 reference

Regulatory T cells mediate maternal tolerance to the fetus

31 March 2020

1 reference

Cellular and molecular mechanisms of liver tolerance

31 March 2020

1 reference

Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals

31 March 2020

1 reference

Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node

31 March 2020

1 reference

The importance of regional lymph nodes for mucosal tolerance

31 March 2020

1 reference

IL-10 controls ultraviolet-induced carcinogenesis in mice

31 March 2020

1 reference

Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora

31 March 2020

1 reference

Friendly and dangerous signals: is the tissue in control?

31 March 2020

1 reference

The danger model: a renewed sense of self

31 March 2020

1 reference

Decoding the patterns of self and nonself by the innate immune system

31 March 2020

1 reference

Debugging how bacteria manipulate the immune response.

31 March 2020

1 reference

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

31 March 2020

1 reference

Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

31 March 2020

1 reference

Dendritic cells in a mature age.

31 March 2020

1 reference

Dendritic cells: emerging pharmacological targets of immunosuppressive drugs

31 March 2020

1 reference

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

31 March 2020

1 reference

Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance.

31 March 2020

1 reference

IDO expression by dendritic cells: tolerance and tryptophan catabolism

31 March 2020

1 reference

Regulation of immune responses by L-arginine metabolism

31 March 2020

1 reference

The PD-1-PD-L pathway in immunological tolerance

31 March 2020

1 reference

A vision of cell death: Fas ligand and immune privilege 10 years later

31 March 2020

1 reference

PD-1 and its ligands in T-cell immunity

31 March 2020

1 reference

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

31 March 2020

1 reference

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

31 March 2020

1 reference

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

31 March 2020

1 reference

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

31 March 2020

1 reference

L-arginine availability regulates T-lymphocyte cell-cycle progression

31 March 2020

1 reference

Tolerogenic dendritic cells and the quest for transplant tolerance

31 March 2020

1 reference

Tolerogenic dendritic cells and regulatory T cells: a two-way relationship

31 March 2020

1 reference

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

31 March 2020

1 reference

Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts.

31 March 2020

1 reference

Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens

31 March 2020

1 reference

Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance

31 March 2020

1 reference

Immune privilege induced by regulatory T cells in transplantation tolerance

31 March 2020

1 reference

Plasmacytoid DCs and T(reg) cells: casual acquaintance or monogamous relationship?

31 March 2020

1 reference

In vivo sites and cellular mechanisms of T reg cell-mediated suppression

31 March 2020

1 reference

The immunobiology of cancer immunosurveillance and immunoediting

31 March 2020

1 reference

Inflammation and cancer: back to Virchow?

31 March 2020

1 reference

Mechanisms and functional significance of tumour-induced dendritic-cell defects

31 March 2020

1 reference

The tumor-draining lymph node as an immune-privileged site

31 March 2020

1 reference

Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity.

31 March 2020

1 reference

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

31 March 2020

1 reference

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

31 March 2020

1 reference

Immune resistance orchestrated by the tumor microenvironment

31 March 2020

1 reference

Regulatory T cells, tumour immunity and immunotherapy

31 March 2020

1 reference

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

31 March 2020

1 reference

Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

31 March 2020

1 reference

Immune privilege in sites of chronic infection: Leishmania and regulatory T cells

31 March 2020

1 reference

Interleukin-10 production by effector T cells: Th1 cells show self control

31 March 2020

1 reference

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

31 March 2020

1 reference

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

31 March 2020

1 reference

CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence

31 March 2020

1 reference

Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection

31 March 2020

1 reference

Induction of indolamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent

31 March 2020

1 reference

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells

31 March 2020

1 reference

Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.

31 March 2020

1 reference

Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.

31 March 2020

1 reference

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

31 March 2020

1 reference

Natural regulatory T cells: mechanisms of suppression

31 March 2020

1 reference

Invariant NKT cells and tolerance

31 March 2020

1 reference

A case for regulatory B cells

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRI2233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18064049%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference